Author:
Buddenini Jaya P.,Chaudhary Kunal,Sowers James R.,Whaley-Connell Adam
Reference73 articles.
1. Chmielewski M, Carrero JJ, Stenvinkel P, Lindholm B (2009) Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk. Curr Opin Lipidol 20:3–9
2. Fried LP, Kronmal RA, Newman AB, Dild DE (1998) Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 279:585–592
3. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636
4. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
5. Wright J, Hutchison A (2009) Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag 5:713–722